id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-3539-0006,FDA,FDA-2024-E-3539,Determination of Regulatory Review Period for Purposes of Patent Extension; BEQVEZ,Notice,Determinations,2026-02-06T05:00:00Z,2026,2,2026-02-06T05:00:00Z,2026-08-06T03:59:59Z,2026-02-14T13:19:52Z,2026-02387,1,0,09000064b9195b4d
FDA-2024-E-3539-0005,FDA,FDA-2024-E-3539,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2025-11-24T05:00:00Z,2025,11,2025-11-24T05:00:00Z,,2025-11-25T02:52:58Z,,0,0,09000064b9094027
FDA-2024-E-3539-0004,FDA,FDA-2024-E-3539,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2025-09-11T04:00:00Z,2025,9,2025-09-11T04:00:00Z,,2025-09-11T17:09:26Z,,0,0,09000064b8f52891
FDA-2024-E-3539-0003,FDA,FDA-2024-E-3539,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2025-08-13T04:00:00Z,2025,8,2025-08-13T04:00:00Z,,2025-08-13T23:26:44Z,,0,0,09000064b8ef9b11
FDA-2024-E-3539-0002,FDA,FDA-2024-E-3539,"Patent Extension Application from Pillsbury Winthrop Shaw Pittman LLP (on behalf of The Children's Hospital of Philadelphia (""CHOP""))",Other,Application,2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T17:46:45Z,,0,0,090000648660d257
FDA-2024-E-3539-0001,FDA,FDA-2024-E-3539,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T17:44:27Z,,0,0,090000648660bf98